The race is on for ICD-10

According to this week’s news, the race is on. The healthcare industry is starting to take seriously the ICD-10 implementation deadline of Oct. 1, 2014.

The results of the HIMSS/WEDI ICD-10 National Pilot Program indicate that any entity touched by the approaching deadline for the new coding system should focus on testing.

"ICD-10-CM/PCS touches almost every aspect of the healthcare continuum," the authors wrote. "All affected entities should be implementing and testing at this point in time. Create a strategy if planning has not begun. Build a solid structure surrounding internal and external testing, engage trading partners early, identify technical and business needs, and engage the business in developing 'day in the life' scenarios."

Average accuracy of the coders involved in the program was 63 percent, with some instances of 100 percent accuracy (e.g., "single live born,  born in the hospital, delivered by Caesarean section"); others (e.g., "pain of the limb") received a 33 percent accuracy score because specificity and laterality were not included.

The authors suggested that providers organizations consider participating in the National Testing Program.

Meanwhile, the Centers for Medicare & Medicaid Services (CMS) may be open to conducting ICD-10 end-to-end testing with physician offices. In the past, the agency said it was confident that its current testing was adequate to handle the new bill coding system but several organizations have expressed concern about the lack of testing. In July, the Medical Group Management Association said in a letter to Health and Human Services Secretary Kathleen Sebelius that it was “extremely concerned” about the lack of testing and had urged the agency to reverse this policy to avoid a “catastrophic” backlog of Medicare claims.

Is your organization on track with ICD-10 implementation? Please share your experience.

Beth Walsh

Clinical Innovation + Technology editor

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year. 

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.